Argosy Research Inc.(TW:3217)
NT$107.00+0.50 (+0.47%)
TW:3217
Argosy Research Inc. financials statements
NT$107.00
At close:+0.50 (+0.47%)
Argosy Research Inc. (3217) Ratios
Argosy Research Inc. Ratios
TW:3217's free cash flow for Q2 2026 was NT$64.81M. For the 2026 fiscal year, TW:3217's free cash flow was decreased by NT$-45.50M and operating cash flow was NT$110.31M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.94 | 3.11 | 3.27 | 3.07 | 2.94 |
| Quick Ratio | 2.45 | 2.62 | 2.73 | 2.56 | 2.41 |
| Cash Ratio | 1.39 | 1.45 | 1.49 | 1.50 | 1.24 |
| Solvency Ratio | 0.86 | 0.92 | 0.84 | 0.78 | 0.74 |
| Operating Cash Flow Ratio | 0.91 | 0.87 | 0.83 | 1.01 | 0.63 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 29.23 | 0.00 |
| Net Current Asset Value | NT$ 2.61B | NT$ 2.38B | NT$ 1.97B | NT$ 1.71B | NT$ 1.76B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.31 | 1.27 | 1.24 | 1.25 | 1.26 |
| Debt Service Coverage Ratio | 4840.94 | 4575.53 | 1277.36 | 24.47 | 3794.69 |
| Interest Coverage Ratio | 5582.76 | 4211.90 | 1224.96 | 2486.91 | 4050.02 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.12 | 0.17 | 0.19 | 0.56 | 0.10 |
| Net Debt to EBITDA | -1.34 | -1.19 | -1.28 | -1.40 | -1.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 49.88% | 50.03% | 46.66% | 39.29% | 42.11% |
| EBIT Margin | 31.49% | 36.44% | 30.79% | 29.17% | 26.72% |
| EBITDA Margin | 34.54% | 40.45% | 35.21% | 34.18% | 30.56% |
| Operating Profit Margin | 31.49% | 30.56% | 27.53% | 29.17% | 26.72% |
| Pretax Profit Margin | 34.79% | 36.43% | 30.77% | 29.16% | 26.71% |
| Net Profit Margin | 27.55% | 29.17% | 24.26% | 23.41% | 21.22% |
| Continuous Operations Profit Margin | 27.55% | 29.17% | 24.26% | 23.41% | 21.19% |
| Net Income Per EBT | 79.21% | 80.08% | 78.85% | 80.28% | 79.45% |
| EBT Per EBIT | 110.47% | 119.22% | 111.77% | 99.95% | 99.98% |
| Return on Assets (ROA) | 18.59% | 17.20% | 13.68% | 12.67% | 13.00% |
| Return on Equity (ROE) | 24.44% | 21.81% | 16.96% | 15.79% | 16.41% |
| Return on Capital Employed (ROCE) | 27.45% | 22.45% | 18.76% | 19.26% | 20.26% |
| Return on Invested Capital (ROIC) | 21.72% | 17.95% | 14.77% | 15.31% | 16.05% |
| Return on Tangible Assets | 18.62% | 17.23% | 13.71% | 12.70% | 13.03% |
| Earnings Yield | 7.98% | 7.19% | 4.59% | 8.50% | 5.26% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.95 | 2.67 | 2.83 | 3.00 | 2.84 |
| Payables Turnover | 7.18 | 7.50 | 8.80 | 11.92 | 8.04 |
| Inventory Turnover | 3.09 | 3.03 | 3.26 | 3.62 | 3.47 |
| Fixed Asset Turnover | 4.19 | 3.71 | 3.34 | 3.05 | 3.72 |
| Asset Turnover | 0.67 | 0.59 | 0.56 | 0.54 | 0.61 |
| Working Capital Turnover Ratio | 1.61 | 1.53 | 1.55 | 1.44 | 1.59 |
| Cash Conversion Cycle | 191.02 | 208.66 | 199.14 | 191.67 | 188.49 |
| Days of Sales Outstanding | 123.67 | 136.90 | 128.82 | 121.56 | 128.64 |
| Days of Inventory Outstanding | 118.15 | 120.47 | 111.80 | 100.72 | 105.23 |
| Days of Payables Outstanding | 50.81 | 48.70 | 41.48 | 30.61 | 45.38 |
| Operating Cycle | 241.83 | 257.36 | 240.62 | 222.28 | 233.87 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 14.00 | 11.23 | 8.51 | 9.77 | 6.61 |
| Free Cash Flow Per Share | 11.58 | 9.69 | 6.06 | 8.13 | 2.83 |
| Dividend Paid and CapEx Coverage Ratio | 1.25 | 1.42 | 1.09 | 1.35 | 0.70 |
| Capital Expenditure Coverage Ratio | 5.79 | 7.31 | 3.47 | 5.97 | 1.75 |
| Operating Cash Flow Coverage Ratio | 121.21 | 66.57 | 45.63 | 17.57 | 65.24 |
| Operating Cash Flow to Sales Ratio | 0.30 | 0.29 | 0.25 | 0.34 | 0.20 |
| Free Cash Flow Yield | 7.28% | 6.19% | 3.43% | 10.17% | 2.10% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 12.53 | 13.92 | 21.76 | 11.76 | 18.99 |
| Price-to-Sales (P/S) Ratio | 3.45 | 4.06 | 5.28 | 2.75 | 4.03 |
| Price-to-Book (P/B) Ratio | 3.06 | 3.04 | 3.69 | 1.86 | 3.12 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 13.73 | 16.15 | 29.14 | 9.83 | 47.69 |
| Price-to-Operating Cash Flow Ratio | 11.36 | 13.94 | 20.74 | 8.19 | 20.42 |
| Price-to-Earnings Growth (PEG) Ratio | 0.97 | 0.36 | 1.13 | -2.70 | -15.19 |
| Enterprise Value Multiple | 8.66 | 8.84 | 13.71 | 6.65 | 11.93 |
| Enterprise Value | 12.40B | 12.42B | 14.50B | 5.93B | 11.00B |
| EV to EBITDA | 8.66 | 8.84 | 13.71 | 6.65 | 11.93 |
| EV to Sales | 2.99 | 3.58 | 4.83 | 2.27 | 3.65 |
| EV to Free Cash Flow | 11.89 | 14.22 | 26.65 | 8.12 | 43.13 |
| EV to Operating Cash Flow | 9.84 | 12.28 | 18.97 | 6.76 | 18.47 |
| Tangible Book Value Per Share | 51.82 | 51.45 | 47.71 | 42.97 | 43.19 |
| Shareholders’ Equity Per Share | 51.93 | 51.56 | 47.82 | 43.08 | 43.30 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.21 | 0.20 | 0.21 | 0.20 | 0.21 |
| Revenue Per Share | 46.06 | 38.55 | 33.43 | 29.06 | 33.48 |
| Net Income Per Share | 12.69 | 11.25 | 8.11 | 6.80 | 7.11 |
| Tax Burden | 0.79 | 0.80 | 0.79 | 0.80 | 0.79 |
| Interest Burden | 1.10 | 1.00 | 1.00 | 1.00 | 1.00 |
| Research & Development to Revenue | 0.06 | 0.07 | 0.06 | 0.07 | 0.06 |
| SG&A to Revenue | 0.12 | 0.13 | 0.13 | 0.12 | 0.10 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| Income Quality | 0.87 | 0.80 | 0.83 | 1.15 | 0.74 |
Currency in TWD
